In order to evaluate the clinical aspects of gram-negative bacillary meningitis (GNBM) we reviewed the charts of 20 adult patients with the discharge diagnosis of meningitis caused by gram-negative bacilli (bacteriologically proved) seen between 1973 and 1984. Nine patients had post-neurosurgical (post-NS) GNBM and 11 patients spontaneous (S) GNBM; the mean age of the former was 42 +/- 16 years and of the latter 56 +/- 14 years (p less than 0.05). The overall mortality rate was 50% (33% in the post-NS group and 64% in the S group). The glucose levels in CSF were significantly lower in the patients who died. Patients treated with combined aminoglycoside therapy presented a lower mortality rate than those treated with intravenous aminoglycoside only (25% versus 70%). We suggest that if aminoglycoside therapy is employed, these antibiotics must be administered both intravenously and directly into CNS.

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365548609021658DOI Listing

Publication Analysis

Top Keywords

gram-negative bacillary
8
bacillary meningitis
8
+/- years
8
mortality rate
8
aminoglycoside therapy
8
patients
5
post-neurosurgical spontaneous
4
spontaneous gram-negative
4
meningitis adults
4
adults order
4

Similar Publications

With increasing antibiotic resistance in gram-negative bacteria, including those causing Shigellosis, evidence of safety and pharmacokinetics data on new oral antibiotics is crucial. We aimed to investigate the safety and pharmacokinetic properties of an oral carbapenem, tebipenem pivoxil, along with it's ability to produce desired results in childhood shigellosis. This randomized pilot clinical trial was conducted at Dhaka Hospital, icddr,b in 2022 between May and September.

View Article and Find Full Text PDF

Differential vasoproliferative traits of strains associated with autotransporter BafA variants.

Microbiol Spectr

January 2025

Laboratory of Bacterial Zoonoses, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

a Gram-negative facultative intracellular bacterium, is the etiological agent of cat-scratch disease and also causes bacillary angiomatosis in immunocompromised individuals. Although the ability to promote vascular endothelial cell proliferation differs among species, variations among strains within remain unclear. angiogenic factor A (BafA) and adhesin A (BadA) have been identified as autotransporters of that are involved in endothelial cell proliferation.

View Article and Find Full Text PDF
Article Synopsis
  • - The study introduces IITR00210, a small nitrile molecule that shows significant antibacterial activity, particularly against multidrug-resistant Gram-negative bacteria and enteropathogens, with the ability to reduce bacterial counts effectively.
  • - IITR00210 works by causing stress to the bacterial cell envelope, disrupting the proton motive force (PMF) and leading to bacterial cell death, while also displaying antibiofilm and antiadhesion properties.
  • - This molecule has demonstrated a strong safety profile, shows effective intracellular activity against bacteria in immune cells, and is promising for treating infections in animal models without developing stable resistance.
View Article and Find Full Text PDF

Introduction: Gram-negative bacillary bacteremia poses a significant threat, ranking among the most severe infectious diseases capable of triggering life-threatening sepsis. Despite the unambiguous involvement of neutrophils in this potentially fatal disease, there are limited data about the molecular signaling mechanisms, phenotype, and function of human neutrophils during the early phase of gram-negative bacillary bacteremia.

Methods: By using an unbiased proteomics and flow cytometry approach, we identified an antigen-presenting cell (APC)-like phenotype in human peripheral blood neutrophils (PMN) with MHC class II molecule expression in the early phase of bacteremia.

View Article and Find Full Text PDF
Article Synopsis
  • Shigellosis, caused by the Shigella bacteria, is a significant global health issue, with no commercial vaccine available despite years of research.
  • This study created a multi-epitope vaccine using E. coli and purified it, then encapsulated the protein in alginate nanoparticles, confirming successful loading and specific particle characteristics.
  • Mice vaccinated orally showed a significant increase in IgG and cytokines IL-4 and IFN-γ, highlighting a strong immune response, making this alginate-based vaccine a promising approach for combatting Shigella infection.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!